Table 1 Clinical characteristics
Clinical characteristics | Total (N = 59) | Group A (N = 29) | Group B (N = 30) | p-value |
|---|---|---|---|---|
Age in years, median (IQR) | 55 (52,68) | 56 (52,62) | 55 (53,68) | 0.6496 |
Sex, n (%) | 0.2184 | |||
Female | 36 (61.02) | 20 (68.97) | 16 (53.33) | |
Male | 23 (38.98) | 9 (31.03) | 14 (46.67) | |
Cancer types, n (%) | ||||
Gastric cancer | 3 (5.08) | 2 (6.90) | 1 (3.33) | 0.5334 |
Colorectal cancer | 39 (66.10) | 19 (65.52) | 20 (66.67) | 0.9257 |
Breast cancer | 15 (25.42) | 6 (20.69) | 9 (30.00) | 0.4116 |
Others | 2 (3.39) | 2 (6.90) | 0 (0.00) | 0.1434 |
Chemotherapy, n (%) | 0.9367 | |||
MEC | 43 (72.88) | 21 (72.41) | 22 (73.33) | |
HEC | 16 (27.12) | 8 (27.59) | 8 (26.67) | |
Baseline EORTC-QLQ-C30 score, mean (SD) | 50.03 ± 14.01 | 47.00 ± 13.10 | 52.97 ± 14.44 | 0.1019 |
Baseline stress score, mean (SD) | 13.90 ± 6.87 | 13.00 ± 7.22 | 14.77 ± 6.53 | 0.3288 |